PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.90%
Net income growth under 50% of AVGO's 13.45%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.16%
Both reduce yoy D&A, with AVGO at -7.32%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-248.39%
Negative yoy deferred tax while AVGO stands at 450.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-7.02%
Negative yoy SBC while AVGO is 28.57%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
37.95%
Less working capital growth vs. AVGO's 160.36%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-131.82%
AR is negative yoy while AVGO is 140.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
46.84%
Inventory shrinking or stable vs. AVGO's 164.29%, indicating lean supply management. David Dodd would confirm no demand shortfall.
100.00%
Lower AP growth vs. AVGO's 250.00%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
42.93%
Lower 'other working capital' growth vs. AVGO's 117.74%. David Dodd would see fewer unexpected short-term demands on cash.
No Data
No Data available this quarter, please select a different quarter.
22.29%
Operating cash flow growth below 50% of AVGO's 274.63%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-42.27%
Negative yoy CapEx while AVGO is 40.63%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
6.30%
Less growth in investment purchases vs. AVGO's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-51.33%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-963.49%
We reduce yoy invests while AVGO stands at 53.66%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-48.57%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
41.37%
Buyback growth of 41.37% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.